top of page

Browse by category

Search

Viking initiates study to evaluate dual GLP-1/GIP receptor agonist VK2735

Viking initiates study to evaluate dual GLP-1/GIP receptor agonist VK2735

Viking Therapeutics has initiated a Phase 1 clinical study to evaluate a novel oral formulation of the company's dual glucagon-like...

RefluxStop results in 90.9% reduction in GERD-HRQL score

1 day ago

Journal watch 18/09/2024

2 days ago

Key factors that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications

4 days ago

bottom of page